切换至 "中华医学电子期刊资源库"

中华脑血管病杂志(电子版) ›› 2020, Vol. 14 ›› Issue (01) : 21 -24. doi: 10.11817/j.issn.1673-9248.2020.01.003

所属专题: 文献

专家论坛

联合抗血小板药物在缺血性脑卒中二级预防中的应用
彭斌1,()   
  1. 1. 100730 中国医学科学院北京协和医院神经科
  • 收稿日期:2019-12-10 出版日期:2020-02-01
  • 通信作者: 彭斌
  • 基金资助:
    国家重点研发计划精准医学研究重点专项子课题(2016YFC0901004)

Dual antiplatelet therapy in secondary ischemic stroke prevention

Bin Peng1,()   

  1. 1. Department of Neurology, Peking Union Medical College Hospital, Beijing 100730, China
  • Received:2019-12-10 Published:2020-02-01
  • Corresponding author: Bin Peng
  • About author:
    Corresponding author: Peng Bin, Email:
引用本文:

彭斌. 联合抗血小板药物在缺血性脑卒中二级预防中的应用[J/OL]. 中华脑血管病杂志(电子版), 2020, 14(01): 21-24.

Bin Peng. Dual antiplatelet therapy in secondary ischemic stroke prevention[J/OL]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2020, 14(01): 21-24.

联合抗血小板药物可有效降低缺血性脑卒中复发风险,但也在一定程度上增加了出血的风险。在临床实践中,使用联合抗血小板药物需要评估,权衡利弊,尤其应对特定的人群、卒中亚型、用药时间、药物种类及数量以及安全性方面进行全面评估,以发挥有效二级预防疗效。

Dual antiplatelet therapy is effective in secondary ischemic stroke prevention. However, increased risk of hemorrhage in some patients was noted. It is necessary to balance the benefit and the risk while combined antiplatelet treatment. Target patients, etiological classifications of stroke, duration of medication, types and amounts of antiplatelet drugs and safety are all important aspects needed to be evaluated.

1
Diener HC, Cunha L, Forbes C, et al. European stroke prevention study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke [J]. J Neurol Sci, 1996, 143(1-2): 1-13.
2
CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) [J]. Lancet, 1996, 348(9038): 1329-1339.
3
ESPRIT Study Group, Halkes PH, van Gijn J, et al. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial [J]. Lancet, 2006, 367(9523): 1665-1673.
4
Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack [J]. N Engl J Med, 2013, 369(1): 11-19.
5
Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA [J]. N Engl J Med, 2018, 379(3): 215-225.
6
Wang Y, Johnston SC, Bath PM, et al. Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack [J]. BMJ, 2019, 364: l895-1898.
7
Kim JT, Park MS, Choi KH, et al. Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Acute, Nonminor Stroke: A Nationwide, Multicenter Registry-Based Study [J]. Stroke, 2019, 50(11): 3147-3155.
8
Adams HP BendixenJr, , Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment [J]. Stroke, 1993, 24(1): 35-41.
9
Jing J, Meng X, Zhao X, et al. Dual antiplatelet therapy in transient ischemic attack and minor stroke with different infarction patterns: subgroup analysis of the CHANCE randomized clinical trial [J]. JAMA Neurol, 2018, 75(6): 711-719.
10
Hong KS, Lee SH, Kim EG, et al. Recurrent ischemic lesions after acute atherothrombotic stroke: clopidogrel plus aspirin versus aspirin alone [J]. Stroke, 2016, 47(9): 2323-2330.
11
Kim D, Park JM, Kang K, et al. Dual Versus mono antiplatelet therapy in large atherosclerotic stroke [J]. Stroke, 2019, 50(5): 1184-1192.
12
SPS3 Investigators, Benavente OR, Hart RG, et al. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke [J]. N Engl J Med, 2012, 367(9): 817-825.
13
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2014 [J]. 中华神经科杂志, 2015, 48(4): 258-273.
14
Investigators ACTIVE, Connolly SJ, Pogue J, et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation [J]. N Engl J Med, 2009, 360(20): 2066-2078.
15
Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial [J]. Lancet, 2004, 364(9431): 331-337.
16
Pan Y, Chen W, Xu Y, et al. Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis [J]. Circulation, 2017, 135(1): 21-33.
17
Johnston SC, Amarenco P, Denison H, Evans SR,et al. The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design [J]. Int J Stroke, 2019, 14(7): 745-751.
18
Frankish H. News from the International Stroke Conference, 2019 [J]. Lancet Neurol, 2019, 18(4): 337.
19
Bath PM, Woodhause LJ, Appleton JP, et al. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus cloplidogrel alone or aspirin and dipyridanmole in patients with acute cerebral ischaemia (TARDIS): a radomised, open-label, phase 3 superiority trial [J]. Lancet, 2018, 391(10123): 850-859.
20
Hilkens NA, Algra A, Diener HC, et al. Predicting major bleeding in patients with noncardioembolic stroke on antiplatelets: S2TOP-BLEED [J]. Neurology, 2017, 89(9): 936-943.
21
Ding L, Peng B. Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a systematic review and meta-analysis [J]. Eur J Neurol, 2018, 25(10): 1276-1284.
[1] 张怡, 王宇洋, 司梦娇, 曹燕, 李欢欢. 脑卒中前白蛋白与肺炎发生风险相关性分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 648-651.
[2] 江西省神经外科质量控制中心. 江西省心源性脑卒中多学科协作防治专家共识[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 264-277.
[3] 张洪, 杨琪, 罗静, 唐茜, 邓鸿, 巩文艳, 王丽坤, 刘静, 艾双春. 多靶点神经调控技术对卒中后上肢运动功能障碍患者的脑网络功能连接研究[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 278-284.
[4] 许方军, 曹晓光, 王修敏, 王婷, 陈冬冬, 余程冬, 张鹤言. 基于闭环理论的动作观察疗法联合躯干控制训练对脑卒中后下肢运动的影响[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 292-299.
[5] 张雅文, 尹昱, 陈江龙, 杨玉慧, 吕红香, 张琦, 吕佩源. Theta爆发式经颅磁刺激治疗失语症的研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 306-311.
[6] 陈冬冬, 余程冬, 曹晓光. 上肢外骨骼机器人在脑卒中康复中的应用与研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 312-317.
[7] 吉莉, 苏云楠, 王斌, 沈滔, 刘团结, 毛蕾, 徐玉萍, 张婷, 王博. 急性缺血性脑卒中患者脑白质微结构改变对长期认知功能损伤的预测价值研究[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(04): 193-200.
[8] 武继敏, 袁春雨, 王鲁佳, 陈伟霞, 李晓东, 马丽虹. 重复经颅磁刺激治疗脑卒中后中枢性疼痛的研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(03): 182-186.
[9] 梁明, 魏珍, 祖合热·肉孜, 李金贤. 超声评估脑卒中气管切开患者膈肌功能与肺功能的相关性研究[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(03): 133-139.
[10] 刘志超, 胡风云, 温春丽. 山西省脑卒中危险因素与地域的相关性分析[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 424-433.
[11] 王丽娜, 吕书霞, 李亚男. 脑卒中偏瘫患者健康焦虑元认知与疾病接受度、恐惧疾病进展的相关性[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 434-440.
[12] 李璇, 邓岚, 郭微, 邓永梅, 刘杰昕. 标准化皮肤管理流程在防治脑卒中患者失禁相关性皮炎中的应用[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 479-482.
[13] 李芳, 戴西望, 王凯, 郭廷昊, 涂江龙. 非瓣膜性心房颤动相关性卒中的治疗研究进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 393-397.
[14] 周洪千, 张煜坤, 顾天舒, 胡苏涛, 姜超, 张雪, 张昊, 陶华岳, 刘行, 刘彤, 陈康寅. 既往出血性脑卒中患者行经皮冠脉介入治疗后不良事件的危险因素分析[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 323-329.
[15] 邓越, 白鹏, 洪秋阳, 王桂玲. 颈部七线调衡疗法探析并病例汇报一例[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 345-349.
阅读次数
全文


摘要